Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR)

  • Event
  • Oct. 14, 2022, 20:17 UTC
  • 58
  • 1 comments

(99% Neutral) TCR2 THERAPEUTICS INC. (TCRR) Files Form 8-K

Comment Full text

ATAI Life Sciences (ATAI)

  • Event
  • Oct. 14, 2022, 20:16 UTC
  • 56
  • 1 comments

(99% Neutral) ATAI LIFE SCIENCES N.V. (ATAI) Files Form 8-K

Comment Full text

BeiGene Ltd (BGNE)

  • Event
  • Oct. 14, 2022, 20:09 UTC
  • 54
  • 1 comments

(90% Positive) BEIGENE, LTD. (BGNE) Provides Update on superiority for publication

Comment Full text

Curis Inc (CRIS)

  • Event
  • Oct. 14, 2022, 20:01 UTC
  • 63
  • 1 comments

(99% Neutral) Curis, Inc. (CRIS) Announces New Board Appointment

Comment Full text

Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX)

  • Event
  • Oct. 14, 2022, 12:48 UTC
  • 61
  • 1 comments

(99% Neutral) FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) Announces Executive Changes

Comment Full text

Chinook Therapeutics Inc (KDNY)

  • Event
  • Oct. 14, 2022, 06:02 UTC
  • 138
  • 0 comments

Chinook Therapeutics Announces Upcoming Presentations and Investor Conference Call at the American Society of Nephrology (ASN) Kidney Week 2022

Comment Full text

Aeglea BioTherapeutics Inc (AGLE)

  • Event
  • Oct. 14, 2022, 02:39 UTC
  • 135
  • 0 comments

Aeglea BioTherapeutics Inc. - KOL Webinar on Classical Homocystinuria and Pegtarviliase

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • Oct. 13, 2022, 14:22 UTC
  • 136
  • 0 comments

New Form 3 for Quantum-Si Incorporated

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • Oct. 13, 2022, 14:22 UTC
  • 139
  • 0 comments

New Form 3 for Quantum-Si Incorporated

Comment Full text

Gilead Sciences Inc (GILD)

  • Event
  • Oct. 13, 2022, 14:09 UTC
  • 133
  • 0 comments

Gilead - Third Quarter 2022 Gilead Sciences Earnings Conference Call

Comment Full text
  • Previous
  • 106
  • 107
  • 108
  • 109
  • 110
  • Next

Search

News categories

  • Technical Exchange News(10868)
  • Event(2240)
  • SEC News(188949)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124484)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin